No Data
No Data
BioHarvest Sciences Announces Closing of USD $4,329,982 in First Tranche of Private Placement and Conversion of Debt Notes
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 28, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) (FSE: 8MV) ("BioHarvest" or the "Company") has closed the first
BioHarvest Sciences Closes First Tranche of Private Placement | CSE:BHSC, OTC:CNVCF
BioHarvest Sciences to Present at Noble Capital Markets Virtual Equity Conference on June 27, 2024
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 24, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) ("BioHarvest" or the "Company"), a company pioneering its patent
BioHarvest Sciences Announces a Private Placement of up to USD $5 Million and Conversion of Debt Notes
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 21, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) ("BioHarvest" or the "Company"), announced today that its board
BioHarvest Sciences Unveils US$5M Financing | CSE:BHSC, OTC:CNVCF
BioHarvest Sciences to Present at Sidoti Small-Cap Virtual Investor Conference on June 13, 2024
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 12, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) ("BioHarvest" or the "Company"), a company pioneering its patent